Related studies indicated that FGF21 is required to limit the progression of HCC carcinogenetic transformation during metabolic liver injury in diabetic subjects, which mainly function at the stage of HCC initiation (Zhang et al., 2015; Singhal et al., 2018). Here, FGF21 is linked to hepatocellular carcinoma.